Live Breaking News & Updates on Verastem Oncology

Stay updated with breaking news from Verastem oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First-Line Metastatic Pancreatic Cancer

Verastem Oncology announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 clinical trial evaluating avutometinib plus defactinib in combination with gemcitabine. ....

United States , Eastern Cooperative Oncology Group , American Society Of Clinical Oncology , Verastem Oncology , American Society , Clinical Oncology , Annual Meeting , Performance Status ,

Verastem Oncology Announces the Initiation of a Rolling Submission of NDA to FDA Seeking Accelerated Approval of Avutometinib and Defactinib Combination for the Treatment of Adult Patients with Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer

Verastem Oncology Announces the Initiation of a Rolling Submission of NDA to FDA Seeking Accelerated Approval of Avutometinib and Defactinib Combination for the Treatment of Adult Patients with Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

South Korea , United Kingdom , Dan Paterson , European Network Of Gynaecological Oncological Trial , Chugai Pharmaceutical Co Ltd , Company Annual Report On Form , Exchange Commission , Raf And Mek Program , Genfleet Therapeutics Shanghai Inc , Secura Bio Inc , Drug Administration , Foundation Inc , Verastem Oncology , New Drug Application , Breakthrough Therapy Designation , Orphan Drug Designation , European Network , Gynaecological Oncological Trial , Blinded Independent Central , Low Grade Serous Ovarian Cancer , Secura Bio , Genfleet Therapeutics , Annual Report ,

What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?

What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

United States , American Society , Verastem Oncology ,

ASCO 2024: Verastem's combo therapy for pancreatic cancer hits early trial success

ASCO 2024: Verastem's combo therapy for pancreatic cancer hits early trial success
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

United States , American Society Of Clinical Oncology , Verastem Oncology , American Society , Clinical Oncology , Annual Meeting ,

Brown Highlights the Rationale for the RAMP-301 Trial in Low-Grade Serous Ovarian Cancer

Brown Highlights the Rationale for the RAMP-301 Trial in Low-Grade Serous Ovarian Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

North Carolina , United States , Ashling Wahner , Live On Air , Verastem Oncology , Jubilee Brown , Gynecologic Oncology , Atrium Health Levine Cancer Institute , Onclive On Air , Apple Podcasts , Google Podcasts , Amazon Music ,